Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.56 |
| ▸ | CTSS | P25774 | 3/20 | 0.56 |
| ▸ | CTSK | P43235 | 3/20 | 0.56 |
| ▸ | CTSH | P09668 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | CCKBR | P32239 | 4/20 | 0.52 |
| ▸ | CCKAR | P32238 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.50 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.50 |
| ▸ | GRPR | P30550 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 2/20 | 0.49 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10419744 | 0.94 | C5AR1 (0.51) | CTSLCTSSCTSKCTSHKEAP1 | |
| SCHEMBL29973199 | 0.92 | CTSL (0.54) | CTSLCTSSCTSKCTSHKEAP1 | |
| SCHEMBL29973259 | 0.90 | GLP1R (0.52) | CTSLCTSSCTSKCTSHCCKBR | |
| SCHEMBL16455227 | 0.89 | CTSL (0.55) | CTSLCTSSCTSKCTSHKEAP1 | |
| SCHEMBL9347526 | 0.88 | CTSL (0.54) | CTSLCTSSCTSKCTSHKEAP1 | |
| SCHEMBL30510367 | 0.87 | MC4R (0.52) | CTSLCTSSCTSKCTSHCCKBR | |
| SCHEMBL29476471 | 0.87 | C5AR1 (0.50) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL29511062 | 0.86 | MC4R (0.51) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL30264960 | 0.86 | CTSL (0.49) | CTSLCTSSCTSKCTSHIL23R | |
| SCHEMBL28714609 | 0.86 | IL23R (0.56) | CTSLCTSSCTSKCTSHCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2025-04-24 | — | — | US | disclosed |
| EP-4404912-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | Ferring B.V. (NL) | 2024-07-31 | — | — | EP | disclosed |
| CN-117979954-A | Corticotropin peptide compositions and methods of use | 辉凌有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023046336-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2023-03-30 | — | — | WO | disclosed |
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | MC2R, CRH, NR5A1 | CTSL 2881/4885CTSS 4787/4885CTSK 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.